Evidence map›Paper›PMID 31986932›Full record

ArticleExpert review of anticancer therapy2020

Early detection and imaging strategies to reveal and target developing pancreatic cancer.

Howard C Crawford, Michael B Wallace, Peter Storz

Abstract readEditorial
In one paragraph

Article in Expert review of anticancer therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Circulating tumor cells in the early detection of human cancers.International journal of biological sciences · 2022
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Howard C CrawfordDepartment of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
Michael B WallaceGastroenterology Department, Mayo Clinic, Jacksonville, FL, USA.
Peter StorzDepartment of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Jacksonville, FL, USA.

Funding

Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas CancerU01CA224145 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CRAWFORD, HOWARD C., PASCA DI MAGLIANO, MARINA · 2017 to 2021
$2.6M
PKD1 signaling in the initiation of pancreatic cancerR01CA200572 · NCI · MAYO CLINIC JACKSONVILLE · PI STORZ, PETER · 2016 to 2021
$1.8M
Role of ICAM1 in development and progression of pancreatic cancerR01CA229560 · NCI · MAYO CLINIC JACKSONVILLE · PI STORZ, PETER · 2019 to 2023
$1.8M
NCI NIH HHS R01 CA200572NCI NIH HHS R01 CA229560NCI NIH HHS U01 CA224145
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdenocarcinomaCarcinoma, Pancreatic DuctalDiagnostic ImagingEarly Detection of CancerHumansPancreatic Neoplasmsearly detectionimagingPancreatic ductal adenocarcinomapancreatic intraepithelial neoplasiaPanIN

Identifiers

PMID31986932
PMCPMC7380330

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.